Skip to main content
    • Aa
    • Aa



Respiratory Distress Syndrome (RDS) is due to immaturity of the lungs, primarily the surfactant synthesising system; hence, the risk of RDS is inversely proportional to gestational age. The incidence of RDS has been reduced by the routine use of both antenatal corticosteroids and postnatal surfactant, but still approximately one per cent of babies develop RDS. Hyaline membranes, formed from plasma proteins which have leaked onto the lung surface through damaged capillaries and endothelial cells, line the terminal airways. Hence, RDS has also been called hyaline membrane disease, but RDS is the preferred name as the presence of hyaline membranes can only be confirmed histologically. The aim of this review is to emphasize the pathophysiology of RDS and the clinical presentation and relevance of diagnostic techniques in the current population of very prematurely born infants, highlighting the differential diagnosis. In addition, the evidence base for prophylactic and management strategies including whether new therapies and techniques of respiratory support have positively impacted on outcomes are discussed. The mortality and long term morbidity associated with very premature birth are described. Our increasing understanding that the so-called new bronchopulmonary dysplasia (BPD) and associated chronic adverse respiratory outcomes in such infants can reflect antenatal events resulting in abnormal lung growth is highlighted.

Corresponding author
Professor A Greenough, Professor of Clinical Respiratory Physiology, Newborn Unit, 4th Floor, Golden Jubilee Wing, King's College Hospital, London SE5 9RS.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1AH Jobe . The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641–43.

2A Hamvas , F Sessions Cole , LM Nogee . Genetic disorders of surfactant proteins. Neonatology 2007; 91: 311–17.

4D Sweet , G Bevilacqua , V Carnielli , G Greison , R Plavka , O Didrik Saugstad European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinatal Med 2007; 35: 175–86.

5D Roberts , S Dalziel . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Sys Rev 2006; 3: CD004454.

6O Baud , L Foix L'Helias , M Kaminski , F Audibert , PH Jarreau , F Papiernik Antenatal glucorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341: 1190–96.

7BH Lee , BJ Stoll , SA McDonald , RD Higgins for the National Institute of Child Health and Human Development Neonatal Research Network. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006; 117: 1503–10.

8P Stutchfield , R Whitaker , I Russell on behalf of the Antenatal Steroids for Term Elective Caesarian Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section. Pragmatic randomised trial. Br Med J 2005; 331: 662.

9CA Crowther , RR Haslam , JE Hiller , LW Doyle , JS Robinson for the Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006; 367: 1913–919.

10NP French , R Hagan , SF Evans , M Godrfrey , JP Newnham . Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114–21

11KE Willet , AH Jobe , M Ikegami , J Newnham , S Brennan , PD Sly . Antenatal endotoxin and glucorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000; 48: 782–88.

12PH Burri . The postnatal growth of the rat lung. III. Morphology. Anat Rec 1975; 180: 7798.

14SG Kallapur , BW Kramer , TJ Moss , JP Newnham , AH Jobe , M Ikegami Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2003; 284: L633–42.

16DA Osborn , RW Hunt . Postnatal thyroid hormones for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2007; 1: CD005946.

17G Eisler , R Hjertberg , H Lagercrantz . Randomised controlled trial of effect of terbutaline before elective caesarian section on postnatal respirations and glucose homeostasis. Arch Dis Child Fetal Neonatal Ed 1999; 80: F88–92.

20WA Engle and the Committee on Fetus and Newborn. Surfactant replacement therapy for respiratory distress syndrome in the preterm and term neonate. Pediatrics 2008; 121: 419–32.

24A Corbet , R Buccciarelli , S Goldman , M Mammel , D Wold , W Long . Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant; a multicenter controlled trial. American Exosurf Pediatric Study Group 1. J Pediatr 1991; 118: 277–84.

28TA Merritt , M Hallman , C Berry , M Pohjavuori , DK Edwards 3rd, J Jaaskelainen Randomised, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr 1991; 118: 581–94.

29HL Halliday . Recent clinical trials of surfactant treatment for neonates. Biol Neonate 2006; 89: 323–29.

30F Moya , S Sinha , J Gadzinowski , R D'Agostino , R Segal , C Guardia on behalf of the SELECT and STAR Study Investigators. One year follow up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomised controlled trials. Pediatrics 2007; 119: e1361e1370.

31RH Pfister , RF Soll , T Wiswell . Protein containing surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2007; 4: CD006069.

35CJ Morley , PG Davis , LW Doyle , L Brion , JM Hascoet , JB Carlin . Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700708.

37A, Dimitriou G, Prendergast M Greenough , AD Milner . Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database Syst Rev 2008; (1): CD000456.

38ZC Reyes , N Claure , MK Tauscher , C D'Ugard , S Vanbuskirk , E Bancalari . Randomised, controlled trial comparing synchronised intermittent mandatory ventilation and synchronised intermittent mandatory ventilation plus pressure support in preterm infants. Pediatrics 2006; 118: 1409–417.

39A Schulze , E Rieger-Fackeldey , T Gerhardt , N Claure , R Everett , E Bancalari . Randomised crossover comparison of proportional assist ventilation and patient triggered ventilation in extremely low birthweight infants with evolving chronic lung disease. Neonatology 2007; 92: 17.

40S Herber-Jonat , E Rieger-Fackeldey , H Hummler , A Schulze . Adaptive mechanical backup ventilation for preterm infants on respiratory assist modes – a pilot study. Intens Care Med 2006; 32: 302308.

41N McCallion , PG Davis , CJ Morley . Volume targeted versus pressure limited ventilation in the neonate. Cochrane Database Syst Rev 2005; 2: CD003666.

43IU Cheema , AK Sinha , ST Kempley , JS Ahluwalia . Impact of volume guarantee ventilation on arterial carbon dioxide tension in newborn infants: a randomized controlled trial. Early Hum Dev 2007; 83: 183–89.

44G Lista , F Castoldi , P Fontana , R Reali , A Reggiani , S Bianchi Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volumes. Pediatr Pulmonol 2006; 41: 357–63.

45DJ Henderson-Smart , T Bhuta , F Cools , M Offringa . Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants (Cochrane review). Cochrane Database Syst Rev 2007; 1: CD000104.

46HIFO Study Group. Randomised study of lung frequency oscillatory ventilation in infants with severe respiratory distress syndrome. Pediatrics 1993; 122: 609–19.

47G Dimitriou , A Greenough , D Broomfield , M Morton . Rescue high frequency oscillation, hypocarbia and neurodevelopmental outcome in preterm infants. Early Hum Dev 2002; 66: 133–41.

51MD Schreiber , K Gin-Mestan , JD Marks , D Huo , G Lee , P Srisuparp . Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349: 2099–107.

52JP Kinsella , GR Cutter , WF Walsh , DR Gerstmann , CL Bose , C Hart Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354–64.

53RA Ballard , WE Truog , A Cnaan , RJ Martin , PL Ballard , JD Merrill : NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355: 343–53.

54K Costeloe on behalf of the EPICure Study Group. EPICure: facts and figures: why preterm labour should be treated. BJOG 2006; 113: 1012.

55Y Kono , J Mishina , T Takamura , H Hara , I Sakuma , S Kusuda Impact of being small for gestational age on survival and long term outcome of extremely premature infants born at 23–27 weeks gestation. J Perinat Med 2007; 35: 447–54.

56A Gonzalez , IR Sosenko , J Chandar , H Hummler , N Claure , E Bancalari . Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 g or less. J Pediatr 1996; 128: 470–78.

57AH Jobe , E Banaclari . NICHD/NHLSI/ORD Workshop Summary. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–29.

58AH Johnson , JL Peacock , A Greenough , N Marlow , ES Limb , L Marston for the United Kingdom Oscillation Study Group. High frequency oscillatory ventilaton for the prevention of chronic lung disease of prematurity. New Engl J Med 2002; 347: 633–42.

60LJ Van Marter , O Ammann , EN Allred , A Leviton , M Pagano , M Moore Chorioamnionitis, mechanical ventilation and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171–76.

61AN Husain , NH Siddiqui , JT Stocker . Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710–17.

62A Greenough , J Alexander , S Burgess , PA Chetcuti , S Cox , W Lenney Home oxygen status on rehospitalisation and primary care requirements of chronic lung disease infants. Arch Dis Child 2002; 86: 4043.

63A Greenough , J Alexander , S Burgess , P Chetcuti , S, Lenny W Cox Health care utilisation of chronic lung disease infants related to hospitalisation for RSV infection. Arch Dis Child 2001; 85: 463–68.

64EJ Vrijlandt , J Gerritsen , H Marike Boezen , EJ Duiverman and the Dutch POPS-19 Collaborative Study Group. Gender differences in respiratory symptoms in 19 year old adults born preterm. Respir Res 2005; 6: 117.

65M Filippone , M Sartor , F Zachello , E Baraldi . Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 2003; 361: 753–54.

66NS Wood , K Costeloe , AT Gibson , EM Hennessy , N Marlow , AR Wilkinson for the EPICure Study Group. The EPICure study: associations and antecedentst of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2005; 90: F134F140.

67N Marlow , D Wolke , MA Bracelwell , M Samara for the Epicure Study Group. Neurologic and developmenteal disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 919.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Fetal and Maternal Medicine Review
  • ISSN: 0965-5395
  • EISSN: 1469-5065
  • URL: /core/journals/fetal-and-maternal-medicine-review
Please enter your name
Please enter a valid email address
Who would you like to send this to? *